Not available
Quote | Evoke Pharma Inc. (NASDAQ:EVOK)
Last: | $0.60 |
---|---|
Change Percent: | 2.25% |
Open: | $0.5901 |
Close: | $0.5868 |
High: | $0.6483 |
Low: | $0.5901 |
Volume: | 15,951 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Evoke Pharma Inc. (NASDAQ:EVOK)
2024-03-21 16:21:33 ET More on Evoke Pharma Evoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call Transcript Evoke Pharma down 28%, prices $30M offering Read the full article on Seeking Alpha For further details see: Evoke Pharma names Matthew D’Onofrio ...
SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced that Matthew J. D’...
Message Board Posts | Evoke Pharma Inc. (NASDAQ:EVOK)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $EVOK News Article - USPTO Grants New Patent to Evoke Pharma Covering the Usage of GIMO | whytestocks | investorshangout | 12/07/2022 1:35:48 PM |
whytestocks: $EVOK News Article - Evoke Pharma Recognizes Gastroparesis Awareness Month through its | whytestocks | investorshangout | 08/01/2022 7:35:55 PM |
znewcar1: ML2.75 MH3.49 flat and no vol | znewcar1 | investorshangout | 07/21/2022 4:01:32 AM |
whytestocks: $EVOK News Article - Evoke Pharma Expands IP Portfolio with Addition of Canadian Patent | whytestocks | investorshangout | 07/06/2022 2:55:53 PM |
Same here with me! I never caught COVID | subslover | investorshub | 06/16/2022 9:44:50 PM |
News, Short Squeeze, Breakout and More Instantly...
SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily ...
SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced that Matthew J. D’...
Fiscal year 2023 net product sales from prescriptions totaled approximately $5.2M, a 107% increase from 2022 Company projects $14M in net revenue for 2024 SOLANA BEACH, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialt...